KLK3 and prostate carcinoma: A single nucleotide polymorphism in ARE1 (PSA −158 G/A) of the PSA gene (rs266882), identified in 1999 (Rao and Cramer, 1999), has been the focus of numerous studies of prostate cancer risk.